Ipamorelin was characterised by Raun and colleagues ( European Journal of Endocrinology , 1998) as the first selective growth-hormone secretagogue, acting on the GHS-R1a receptor cloned by Howard and colleagues ( Science , 1996)
Moreover, peptide therapy aligns with the growing trend of personalized medicine
While results vary, the antioxidant role of glutathione in reducing oxidative stress is a commonly cited reason some patients inquire about this treatment
Current guidelines recommend either class for people with type 2 diabetes mellitus and established ASCVD, high cardiovascular risk, HF, or CKD [84,85]
When consumers are online shopping, that line can become blurred